oritavancin

Known as: Chlorobiphenyl-chloroeremomycin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

Review

2016

Review

2016

Infections with multi-drug resistant bacteria are increasing worldwide. Glycopeptides, linezolid, daptomycin and 5th generation…

Review

2016

Review

2016

Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic review s. The intent is to…

2014

2014

2009

Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against a wide range of bacteria. Methods for the…

2009

on 18–20 november 2008, the fDA’s anti-infective drugs advisory committee discussed three new drug applications for the treatment…

2008

Glycopeptide antibiotics, for example oritavancin show significant activity against both vegetative type and C. difficile spores…

2008

2 The inhaled form of Bacillus anthracis infection may be fatal to humans. The current standard of 18 care for inhalational…

2008

Staphylococcus aureus is a widespread pathogenic bacterium causing infections that are difficult-to-treat for several reasons…

2003

The pharmacokinetics and pharmacodynamics of oritavancin (LY333328), a glycopeptide antibiotic with concentration-dependent…